Open-Angle Glaucoma (OAG) Market Report 2026
Download Free Sample Buy Now
Open-Angle Glaucoma (OAG) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Open-Angle Glaucoma (OAG) Market Report 2026

Global Outlook – By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types), By Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Open-Angle Glaucoma (OAG) Market Overview

• Open-Angle Glaucoma (OAG) market size has reached to $6.53 billion in 2025

• Expected to grow to $8.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%

• Growth Driver: Growing Awareness Of Eye Illnesses Drives Growth In The Market

• Market Trend: Innovative Devices Revolutionize Glaucoma Treatment With Minimally Invasive Solutions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Open-Angle Glaucoma (OAG) Market?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.

The main disease types in open-angle glaucoma (OAG) are open angle glaucoma, angle closure glaucoma, and others. Open-angle glaucoma is a chronic eye condition characterized by increased intraocular pressure leading to gradual optic nerve damage and potential vision loss, often without early symptoms. The drug classes used in the treatment are prostaglandin analogs, beta blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others. The end users include hospitals, homecare, specialty clinics, and others. It is distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

Open-Angle Glaucoma (OAG) Market Global Report 2026 Market Report bar graph

What Is The Open-Angle Glaucoma (OAG) Market Size and Share 2026?

The open-angle glaucoma (oag) market size has grown strongly in recent years. It will grow from $6.53 billion in 2025 to $6.96 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to limited access to in-person mental health services, rising prevalence of anxiety and depression, increasing awareness of mental health importance, growing use of early telemedicine platforms, early adoption of online counseling programs.

What Is The Open-Angle Glaucoma (OAG) Market Growth Forecast?

The open-angle glaucoma (oag) market size is expected to see strong growth in the next few years. It will grow to $8.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising demand for accessible online therapy, increasing adoption of mobile and web-based counseling tools, growing integration of ai-powered mental wellness solutions, rising use of hybrid therapy models combining individual and group sessions, expansion of online therapy offerings in commercial and residential segments. Major trends in the forecast period include rising adoption of prostaglandin analog drugs, increasing use of minimally invasive glaucoma surgeries, growing awareness about early diagnosis and screening, rising teleophthalmology consultations for oag management, increasing development of combination drug therapies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Open-Angle Glaucoma (OAG) Market Segmentation

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Is The Driver Of The Open-Angle Glaucoma (OAG) Market?

The growing awareness of eye illnesses is expected to propel the growth of the open-angle glaucoma (OAG) market going forward. Eye illnesses encompass medical conditions impacting the structure, function, or vision of the eyes, ranging from minor concerns such as dry eye to serious diseases such as glaucoma and macular degeneration. Their prevalence is rising due to aging populations, prolonged screen exposure, increasing diabetes cases, environmental pollution, and lifestyle habits that strain eye health. Open-angle glaucoma (OAG), a leading cause of blindness, especially among older adults, underscores the critical need for routine eye exams, early diagnosis, and proactive treatment to safeguard against irreversible vision loss. For instance, in October 2023, according to the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, eye care outpatient appointments in the UK exceeded eight million in 2021/22, making it the most in-demand specialty. Additionally, the number of individuals with sight loss, currently surpassing two million, is projected to double to over four million by 2050. Therefore, the growing awareness of eye illnesses is driving growth in the open-angle glaucoma (OAG) industry.

Key Players In The Global Open-Angle Glaucoma (OAG) Market

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Global Open-Angle Glaucoma (OAG) Market Trends and Insights

Major companies operating in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market?

In July 2024, Alcon Inc., a Switzerland-based ophthalmology company, acquired BELKIN Vision Ltd. for $81 million. This acquisition aims to enhance Alcon's glaucoma portfolio by introducing the direct selective laser trabeculoplasty (DSLT) device, a cutting-edge first-line laser treatment for managing open-angle glaucoma. The move aligns with Alcon's strategy to globally expand access to innovative and minimally invasive glaucoma treatments. BELKIN Vision Ltd. is an Israel-based medical device company providing devices for open-angle glaucoma treatments.

Regional Outlook

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (OAG) market consists of revenues earned by entities by providing services such as optometric services, surgical interventions, medication management, and patient education and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The open-angle glaucoma (OAG) market also includes sales of tonometers, visual field analyzers, and lubricating eye drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Open-Angle Glaucoma (OAG) Market Report 2026?

The open-angle glaucoma (oag) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the open-angle glaucoma (oag) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Open-Angle Glaucoma (OAG) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $6.96 billion
Revenue Forecast In 2035 $8.86 billion
Growth Rate CAGR of 6.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Disease Type, Drug Class, End User, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Open-Angle Glaucoma (OAG) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Open-Angle Glaucoma (OAG) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Open-Angle Glaucoma (OAG) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Open-Angle Glaucoma (OAG) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Rising Adoption Of Prostaglandin Analog Drugs

4.2.2 Increasing Use Of Minimally Invasive Glaucoma Surgeries

4.2.3 Growing Awareness About Early Diagnosis And Screening

4.2.4 Rising Teleophthalmology Consultations For Oag Management

4.2.5 Increasing Development Of Combination Drug Therapies

5. Open-Angle Glaucoma (OAG) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare

5.3 Specialty Clinics

5.4 Other End Users

6. Open-Angle Glaucoma (OAG) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Open-Angle Glaucoma (OAG) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Open-Angle Glaucoma (OAG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Open-Angle Glaucoma (OAG) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Open-Angle Glaucoma (OAG) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Open-Angle Glaucoma (OAG) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Open-Angle Glaucoma (OAG) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Open-Angle Glaucoma (OAG) Market Segmentation

9.1. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

9.2. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

9.3. Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End Users

9.4. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

9.5. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma (OAG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

9.6. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

9.7. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

10. Open-Angle Glaucoma (OAG) Market Regional And Country Analysis

10.1. Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Open-Angle Glaucoma (OAG) Market

11.1. Asia-Pacific Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Open-Angle Glaucoma (OAG) Market

12.1. China Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Open-Angle Glaucoma (OAG) Market

13.1. India Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Open-Angle Glaucoma (OAG) Market

14.1. Japan Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Open-Angle Glaucoma (OAG) Market

15.1. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Open-Angle Glaucoma (OAG) Market

16.1. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Open-Angle Glaucoma (OAG) Market

17.1. South Korea Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Open-Angle Glaucoma (OAG) Market

18.1. Taiwan Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Open-Angle Glaucoma (OAG) Market

19.1. South East Asia Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Open-Angle Glaucoma (OAG) Market

20.1. Western Europe Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Open-Angle Glaucoma (OAG) Market

21.1. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Open-Angle Glaucoma (OAG) Market

22.1. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Open-Angle Glaucoma (OAG) Market

23.1. France Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Open-Angle Glaucoma (OAG) Market

24.1. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Open-Angle Glaucoma (OAG) Market

25.1. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Open-Angle Glaucoma (OAG) Market

26.1. Eastern Europe Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Open-Angle Glaucoma (OAG) Market

27.1. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Open-Angle Glaucoma (OAG) Market

28.1. North America Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Open-Angle Glaucoma (OAG) Market

29.1. USA Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Open-Angle Glaucoma (OAG) Market

30.1. Canada Open-Angle Glaucoma (OAG) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Open-Angle Glaucoma (OAG) Market

31.1. South America Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Open-Angle Glaucoma (OAG) Market

32.1. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Open-Angle Glaucoma (OAG) Market

33.1. Middle East Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Open-Angle Glaucoma (OAG) Market

34.1. Africa Open-Angle Glaucoma (OAG) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Open-Angle Glaucoma (OAG) Market Regulatory and Investment Landscape

36. Open-Angle Glaucoma (OAG) Market Competitive Landscape And Company Profiles

36.1. Open-Angle Glaucoma (OAG) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Open-Angle Glaucoma (OAG) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Open-Angle Glaucoma (OAG) Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Open-Angle Glaucoma (OAG) Market Other Major And Innovative Companies

Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc.

38. Global Open-Angle Glaucoma (OAG) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market

40. Open-Angle Glaucoma (OAG) Market High Potential Countries, Segments and Strategies

40.1 Open-Angle Glaucoma (OAG) Market In 2030 - Countries Offering Most New Opportunities

40.2 Open-Angle Glaucoma (OAG) Market In 2030 - Segments Offering Most New Opportunities

40.3 Open-Angle Glaucoma (OAG) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Open-Angle Glaucoma (OAG) Market, Overview Of Key Products - Product Examples
  • Table 2: Global Open-Angle Glaucoma (OAG) Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Open-Angle Glaucoma (OAG) Market, Supply Chain Analysis
  • Table 4: Global Open-Angle Glaucoma (OAG) Market, Major Raw Material Providers
  • Table 5: Global Open-Angle Glaucoma (OAG) Market, Major Resource Providers
  • Table 6: Global Open-Angle Glaucoma (OAG) Market, Major Manufacturers (Suppliers)
  • Table 7: Global Open-Angle Glaucoma (OAG) Market, Major Distributors And Channel Partners
  • Table 8: Global Open-Angle Glaucoma (OAG) Market, Key Technologies & Future Trends
  • Table 9: Global Open-Angle Glaucoma (OAG) Market, Major Trends
  • Table 10: Global Open-Angle Glaucoma (OAG) Market, Major End Users
  • Table 11: Global Open-Angle Glaucoma (OAG) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Open-Angle Glaucoma (OAG) Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Open-Angle Glaucoma (OAG) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Open-Angle Glaucoma (OAG) Market - TAM, US$ Billion, 2025
  • Table 15: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma (OAG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Open-Angle Glaucoma (OAG) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Open-Angle Glaucoma (OAG) Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: Merck & Co. Inc. Financial Performance
  • Table 100: AbbVie Inc. Financial Performance
  • Table 101: Novartis AG Financial Performance
  • Table 102: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 103: Global Open-Angle Glaucoma (OAG) Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Open-Angle Glaucoma (OAG) Market, Competitive Dashboard
  • Table 105: Global Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 107: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 108: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

List Of Figures

    Figure 1: Global Open-Angle Glaucoma (OAG) Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Open-Angle Glaucoma (OAG) Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Open-Angle Glaucoma (OAG) Market, Supply Chain Analysis
  • Figure 4: Global Open-Angle Glaucoma (OAG) Market, Major Raw Material Providers
  • Figure 5: Global Open-Angle Glaucoma (OAG) Market, Major Resource Providers
  • Figure 6: Global Open-Angle Glaucoma (OAG) Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Open-Angle Glaucoma (OAG) Market, Major Distributors And Channel Partners
  • Figure 8: Global Open-Angle Glaucoma (OAG) Market, Key Technologies & Future Trends
  • Figure 9: Global Open-Angle Glaucoma (OAG) Market, Major Trends
  • Figure 10: Global Open-Angle Glaucoma (OAG) Market, Major End Users
  • Figure 11: Global Open-Angle Glaucoma (OAG) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Open-Angle Glaucoma (OAG) Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Open-Angle Glaucoma (OAG) Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Open-Angle Glaucoma (OAG) Market - TAM, US$ Billion, 2025
  • Figure 15: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma (OAG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Open-Angle Glaucoma (OAG) Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Open-Angle Glaucoma (OAG) Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: Merck & Co. Inc. Financial Performance
  • Figure 100: AbbVie Inc. Financial Performance
  • Figure 101: Novartis AG Financial Performance
  • Figure 102: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 103: Global Open-Angle Glaucoma (OAG) Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Open-Angle Glaucoma (OAG) Market, Competitive Dashboard
  • Figure 105: Global Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 107: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 108: Global, Open-Angle Glaucoma (OAG) Market Size Gain ($ Billion), Segmentation By End User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Glaucoma Surgery Devices Market Report 2026 - Global Outlook – By Product (Drainage Systems, Laser-Based Devices, Implants), By Treatment (Open-Angle, Closed-Angle), By Type Of Surgery (Angle Closure Glaucoma Surgery, Aq...

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report 2026 - Global Outlook – By Product Type (Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devic...

Ocular Hypertension Treatment Market Report 2026 - Global Outlook – By Type (Intraocular Hypertension, Glaucoma), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Ho...

Ocular Implants Market Report 2026 - Global Outlook – By Product (Intraocular Lens, Corneal Implants, Orbital Implants, Glaucoma Implants), By Application (Cataract Surgery, Glaucoma Management And Surgery, Corneal Disor...

Retinal Vein Occlusion Market Report 2026 - Global Outlook – By Type (Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion), By Condition (Non-Ischemic, Ischemic), By Diagnosis (Optical Coherence Tomography, Fun...

Ocular Drug Delivery Market Report 2026 - Global Outlook – By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies), By Formulati...

Optic Atrophy Management Market Report 2026 - Global Outlook – By Drug Type (Disulfiram, Amebicides, Ethambutol, Isoniazid, Chloramphenicol, Vincristine, Ciclosporin, Cimetidine), By Route Of Administration (Oral, Inject...

Ophthalmic Devices Market Report 2026 - Global Outlook – By Device (Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmi...

Frequently Asked Questions

The Open-Angle Glaucoma (OAG) market was valued at $6.53 billion in 2025, increased to $6.96 billion in 2026, and is projected to reach $8.86 billion by 2030.

The global Open-Angle Glaucoma (OAG) market is expected to grow at a CAGR of 6.2% from 2026 to 2035 to reach $8.86 billion by 2035.

Some Key Players in the Open-Angle Glaucoma (OAG) market Include, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc. .

Major trend in this market includes: Innovative Devices Revolutionize Glaucoma Treatment With Minimally Invasive Solutions. For further insights on this market. request a sample here

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us